T. Rowe Price Associates
ETNB

T. Rowe Price Associates’s 89bio ETNB Stock Holding History

T. Rowe Price Associates’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-86,256
Closed -$1.27M – 3099
2025
Q3 		$1.27M Buy
86,256
+6,227
+8% +$63.5K ﹤0.01% 1954
2025
Q2 		$786K Buy
80,029
+17,726
+28% +$147K ﹤0.01% 2093
2025
Q1 		$453K Buy
62,303
+15,011
+32% +$131K ﹤0.01% 2286
2024
Q4 		$370K Buy
47,292
+4,976
+12% +$41K ﹤0.01% 2415
2024
Q3 		$314K Buy
42,316
+8,134
+24% +$68.4K ﹤0.01% 2455
2024
Q2 		$274K Buy
34,182
+2,961
+9% +$26.4K ﹤0.01% 2457
2024
Q1 		$364K Buy
31,221
+7,000
+29% +$77.5K ﹤0.01% 2343
2023
Q4 		$271K Sell
24,221
-358,024
-94% -$3.29M ﹤0.01% 2423
2023
Q3 		$5.9M Buy
382,245
+361,027
+1,702% +$6.06M ﹤0.01% 1148
2023
Q2 		$403K Buy
+21,218
New +$373K ﹤0.01% 2231
2021
Q2 		– Sell
-8,513
Closed -$202K – 2931
2021
Q1 		$202K Sell
8,513
-6,428
-43% -$148K ﹤0.01% 2692
2020
Q4 		$364K Buy
+14,941
New +$382K ﹤0.01% 2361

Other funds holding ETNB

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

T. Rowe Price Associates's ETNB Position: Q4 2025 in Review

T. Rowe Price Associates sold out of 89bio (ETNB) in Q4 2025, closing a stake of 86,256 shares — an estimated $1.27M sold.

T. Rowe Price Associates first reported a position in ETNB in Q4 2020 and held it in 12 quarters. The position peaked at $5.9M in Q3 2023. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

  • T. Rowe Price Associates reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
  • T. Rowe Price Associates sold 86,256 89bio shares in Q4 2025, an estimated $1.27M.
  • T. Rowe Price Associates first reported a position in 89bio in Q4 2020 and held it in 12 quarters.
  • T. Rowe Price Associates's 89bio position peaked at $5.9M in Q3 2023.
  • 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on T. Rowe Price Associates's 13F filing for Q4 2025, filed 17 Feb 2026.